3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.

Although several flavonoids have been reported to exert inhibitory effects on influenza H1N1 neuraminidase (NA), little is known about the structure-activity relationship and binding mode. Three dimensional QSAR (quantitative structure-activity relationship) and molecular docking approaches were applied to explore the structural requisites of flavone derivatives for NA inhibitory activity. A meaningful QSAR model with R(2) of 0.5968, Q(2) of 0.6457, and Pearson-R value of 0.8679, was constructed. From the QSAR model, it could be seen how 6-OH, 3'-OH, 4'-OH, and 8-position substituent affect the NA inhibitory activity. Molecular docking study between the most active compound and NA suggested that hydrogen bonds, hydrophobic and electrostatic interactions were closely related to NA inhibitory activity, 5-OH and 7-OH may be essential for this activity. The results provide a set of useful guidelines for the rational design of novel NA inhibitors.

[1]  Andrew G Mercader,et al.  QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. , 2010, European journal of medicinal chemistry.

[2]  R. Fink,et al.  Elderberry flavonoids bind to and prevent H1N1 infection in vitro. , 2009, Phytochemistry.

[3]  David E. Shaw,et al.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..

[4]  Woo Song Lee,et al.  Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition. , 2009, Bioorganic & medicinal chemistry letters.

[5]  G. Du,et al.  Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. , 2008, Bioorganic & medicinal chemistry.

[6]  N R Taylor,et al.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. , 1998, Journal of medicinal chemistry.

[7]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[8]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[9]  W. Oh,et al.  C-Methylated Flavonoids from Cleistocalyx operculatus and Their Inhibitory Effects on Novel Influenza A (H1N1) Neuraminidase. , 2010, Journal of natural products.

[10]  Shuang-Cheng Ma,et al.  Antiviral flavonoids from the seeds of Aesculus chinensis. , 2004, Journal of natural products.

[11]  David A. Evans,et al.  3D QSAR Methods: Phase and Catalyst Compared , 2007, J. Chem. Inf. Model..

[12]  K. Kinoshita,et al.  Anti-influenza virus activity of biflavonoids. , 2007, Bioorganic & medicinal chemistry letters.

[13]  Keun Woo Lee,et al.  Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition. , 2008, Bioorganic & medicinal chemistry letters.

[14]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors , 2007, Nature Reviews Drug Discovery.

[15]  Yao-lan Li,et al.  Antiviral flavans from the leaves of Pithecellobium clypearia. , 2006, Journal of natural products.

[16]  Nobuhiro Suzuki,et al.  Complexity in influenza virus targeted drug design: interaction with human sialidases. , 2010, Journal of medicinal chemistry.